Psoriasis is an incurable autoimmune disease characterized by patches of abnormal red, itchy and scaly skin. This work examined the modulation of inflammation, hyperproliferation and immune cell markers following topical application of fish oil (
FO
) in comparison to the antipsoriatic agents, betamethasone dipropionate (
BD
) and salicylic acid (
SA
), to GsdmA3
Dfl
/+ mice, a hair loss mutant which also exhibits epidermal hyperproliferation akin to psoriasis. The mice were dosed with 100 mg of the test formulation and after 10 days, the mice were sacrificed, skin sections excised and subjected to immunohistochemical determination of
COX
‐2, K17 and
MAC
‐1; and immunofluorescence of Ki‐67. Unchanged expression of the proinflammatory enzyme
COX
‐2 was observed in all treatments, suggesting the noninvolvement of
COX
‐2 in the aetiology of cutaneous aberration seen in GsdmA3
Dfl
/+ mice. Intense staining of K17 and
MAC
‐1 in the
FO
‐treated group mirrored the epidermal thickening seen observed in live mice by optical coherence tomography (
OCT
). The ratio of Ki‐67‐positive nuclei per 100 basal cells indicated that hyperproliferation of keratinocytes occurred in
FO
‐treated mice and the opposite was true for
BD
‐treated mice. There was a positive correlation (
R
2
0.995) between Ki‐67 and the epidermal thickness data observed previously. In all immunochemical procedures, the combined
BD
,
SA
and
FO
formulation did not show any significant difference with the control group, reflecting observations seen previously. In conclusion, the epidermal changes observed following topical
FO
treatment on GsdmA3
Dfl
/+ mice involves an increase in cellular proliferation and macrophages, although
COX
‐2 does not appear to play an important role.